A study published in JAMA Cardiology found that legislation to reduce sodium in processed food in South Africa is linked to significant declines in blood pressure levels. The reduction in sodium intake has been associated with lower rates of cardiovascular disease mortality and stroke, potentially saving millions of lives globally.
A study found that semaglutide significantly improved maximal walking distance in people with symptomatic peripheral artery disease (PAD) and Type 2 diabetes. Patients taking semaglutide also experienced improvements in symptoms and quality of life compared to those on a placebo.
An AI model has been developed to detect blocked coronary arteries based on ECG readings, achieving high accuracy and outperforming expert clinicians. The model could help physicians quickly identify patients who require urgent treatment for a heart attack.
A four-year study presented at the American College of Cardiology's Annual Scientific Session found that oral semaglutide reduced cardiovascular death, heart attack, and stroke by 14% compared to a placebo. The drug's benefits are comparable to injectable forms and offer an alternative for patients who prefer not to take injections.
This study reveals clear periodic patterns in seismic velocity changes on daily, semi-daily, and monthly timescales, driven by tidal forces. The research provides new insights into how tidal forces impact fault systems, offering valuable information for understanding fault dynamics and seismic hazards.
A study presented at the American College of Cardiology's Annual Scientific Session found that dapagliflozin significantly reduced the rate of worsening heart failure in elderly patients with heart failure undergoing transcatheter aortic valve replacement. The trial, called DapaTAVI, enrolled 1,257 patients and showed a 28% lower rate ...
The new robot is shaped like a small propeller and uses an external magnetic field to generate lift and control its flight path. It is less than 1 centimeter in diameter and weighs only 21 milligrams, making it the world's smallest wireless flying robot capable of controlled flight.
A new study finds that prothrombin concentrate is superior to frozen plasma in controlling bleeding during heart surgery, reducing major bleeding events by nearly 50%. The concentrated product caused fewer adverse effects and saved hospitals resources, suggesting a potential shift in treatment guidelines.
In an open-label study, patients hospitalized for a serious heart attack who received rivaroxaban or warfarin had similar efficacy and safety outcomes. Rivaroxaban showed comparable results in dissolving left ventricular blood clots at three months follow-up.
A Phase 2b trial found lorundrostat significantly reduced blood pressure in patients with uncontrolled hypertension by 7.9 mm Hg and 6.5 mm Hg compared to placebo at 12 weeks. The drug showed an acceptable side effect profile, with consistent patterns across secondary endpoints.
Researchers studied women with ischemia symptoms without blockages in their heart arteries. The five-year trial found no significant difference between intensive medical therapy and usual care for serious cardiovascular events.
A new study found that three months of dual antiplatelet therapy (DAPT) was better than one month for reducing heart attacks, strokes, and other adverse events without increasing bleeding risk in high-risk patients. For low-risk patients, three months of DAPT was comparable to 12 months in reducing adverse events, while being better th...
Researchers mapped China's wetlands from 1980 to 2020, revealing a net loss of ~60.9 × 10^3 km^2 due to climate change and human impacts. Meanwhile, the study highlights the importance of sustainable management and conservation strategies to mitigate these losses.
A new study has found that a lower dose of the blood-thinning medication apixaban is as effective as the full dose in preventing recurring blood clots in patients with active cancer. Patients who received the lower dose experienced fewer bleeding complications and similar VTE recurrence rates compared to those on the standard dose.
A new antidote, bentracimab, safely restored platelet function in patients on ticagrelor, reducing the risk of bleeding during urgent surgery or major bleeding events. The study showed similar results for surgical and bleeding patients, with 94.3% achieving normal blood clotting after treatment.
Researchers developed Cu/Zn solid-solution phase hosts to overcome electrochemical limitations in multivalent metal ion batteries. The material's layered crystal structure and abundant interlayer confined species provide favorable diffusion pathways for charge carriers.
A new study developed an AI-powered algorithm that accurately predicted sudden cardiac death risk in over 70% of cases. The algorithm analyzed data from 240,000 ambulatory electrocardiograms and identified patients at risk of severe arrhythmias within two weeks.
A new clinical trial found that oral semaglutide can significantly reduce cardiovascular events in people with type 2 diabetes and pre-existing cardiovascular disease. The medication decreased the risk of major cardiac events by 14% compared to placebo, with nonfatal myocardial infarction seeing the greatest reductions in risk.
The European Society of Cardiology has released a groundbreaking consensus statement on conduction system pacing, offering updated guidance for healthcare professionals on selecting patients. Conduction system pacing is being increasingly adopted due to its perceived ease of implantation and superior electrical performance.
A large new study of over 40,000 patients found that a zero coronary artery calcium score continues to be an accurate indicator of low risk for coronary heart events even as people age. Patients with a zero plaque burden had a two to three times lower risk of death from any cause, including in seniors.
A study published in JAMA Cardiology found that finerenone was effective in treating heart failure, regardless of the presence of atrial fibrillation. New-onset atrial fibrillation was linked to a substantially increased risk of adverse outcomes.
A randomized clinical trial found prothrombin complex concentrate to have superior hemostatic efficacy compared to frozen plasma in patients requiring coagulation factor replacement during cardiac surgery. The study also showed safety advantages for the use of prothrombin complex concentrate.
A new study compares prescribing recommendations based on traditional risk factors vs. coronary artery calcium scoring. The study found that patients assessed using the Pooled Cohort Equation had a higher rate of statin medication recommendations than those assessed using the coronary artery calcium score, with 50.7% vs. 22.3% respecti...